Dominic V. Simone

Array ( [id] => 20207497 [patent_doc_number] => 20250277217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-09-04 [patent_title] => METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY CONDITIONS ASSOCIATED WITH INFECTIOUS DISEASE [patent_app_type] => utility [patent_app_number] => 19/098197 [patent_app_country] => US [patent_app_date] => 2025-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13451 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19098197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20192350 [patent_doc_number] => 20250269060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-28 [patent_title] => UTILIZATION OF GENE TARGETING ANTIBODY FUSION PROTEINS TO PERFORM IN VIVO THERAPEUTIC GENE EDITING [patent_app_type] => utility [patent_app_number] => 19/094456 [patent_app_country] => US [patent_app_date] => 2025-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23738 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19094456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20231358 [patent_doc_number] => 20250288677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-09-18 [patent_title] => MULTIPHASIC LOCALIZED IN VIVO MOLECULAR DELIVERY [patent_app_type] => utility [patent_app_number] => 19/080387 [patent_app_country] => US [patent_app_date] => 2025-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19080387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20762853 [patent_doc_number] => 20260159832 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-06-11 [patent_title] => RNA-EDITING OLIGONUCLEOTIDES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 19/051812 [patent_app_country] => US [patent_app_date] => 2025-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27814 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 378 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19051812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20336756 [patent_doc_number] => 20250340876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-11-06 [patent_title] => RNA-EDITING OLIGONUCLEOTIDES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 19/039578 [patent_app_country] => US [patent_app_date] => 2025-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27798 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 296 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19039578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19724337 [patent_doc_number] => 20250027088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-23 [patent_title] => Compositions and Methods of Generating Novel amiRNA [patent_app_type] => utility [patent_app_number] => 18/899181 [patent_app_country] => US [patent_app_date] => 2024-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6068 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18899181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19643219 [patent_doc_number] => 20240417739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-19 [patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF BLEEDING DISORDERS [patent_app_type] => utility [patent_app_number] => 18/812463 [patent_app_country] => US [patent_app_date] => 2024-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19854 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18812463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19601423 [patent_doc_number] => 20240392303 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-28 [patent_title] => RNA TARGETING OF MUTATIONS VIA SUPPRESSOR tRNAs AND DEAMINASES [patent_app_type] => utility [patent_app_number] => 18/786394 [patent_app_country] => US [patent_app_date] => 2024-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25130 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18786394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20226322 [patent_doc_number] => 12414962 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-16 [patent_title] => Method for treating [patent_app_type] => utility [patent_app_number] => 18/782965 [patent_app_country] => US [patent_app_date] => 2024-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 28234 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 556 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18782965 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20272227 [patent_doc_number] => 12441997 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-10-14 [patent_title] => Method of preparing self-circularized RNA [patent_app_type] => utility [patent_app_number] => 18/775784 [patent_app_country] => US [patent_app_date] => 2024-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 31 [patent_no_of_words] => 15872 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 307 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18775784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19112788 [patent_doc_number] => 20240124538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-18 [patent_title] => Modulation of Wnt5a to Treat Glaucoma [patent_app_type] => utility [patent_app_number] => 18/522141 [patent_app_country] => US [patent_app_date] => 2023-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2006 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18522141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18939643 [patent_doc_number] => 20240034782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-01 [patent_title] => Weight Loss Regimen [patent_app_type] => utility [patent_app_number] => 18/365991 [patent_app_country] => US [patent_app_date] => 2023-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8382 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18365991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18771159 [patent_doc_number] => 20230365970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-16 [patent_title] => Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses Thereof [patent_app_type] => utility [patent_app_number] => 18/361363 [patent_app_country] => US [patent_app_date] => 2023-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 110013 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18361363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19020496 [patent_doc_number] => 20240076667 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-07 [patent_title] => APPLICATION OF ANTISENSE OLIGONUCLEOTIDE TARGETING PBX1 PROMOTER REGION G-QUADRUPLEX IN PREPARATION OF MEDICINE FOR TREATING MELANOMA [patent_app_type] => utility [patent_app_number] => 18/349353 [patent_app_country] => US [patent_app_date] => 2023-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5760 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18349353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18862308 [patent_doc_number] => 20230416744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-28 [patent_title] => METHODS AND COMPOSITIONS FOR INCREASED DOUBLE STRANDED RNA PRODUCTION [patent_app_type] => utility [patent_app_number] => 18/342407 [patent_app_country] => US [patent_app_date] => 2023-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11926 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18342407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18673018 [patent_doc_number] => 20230310483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-05 [patent_title] => MODULATORS OF HSD17B13 EXPRESSION [patent_app_type] => utility [patent_app_number] => 18/334632 [patent_app_country] => US [patent_app_date] => 2023-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 77000 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18334632 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18707621 [patent_doc_number] => 20230330198 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-19 [patent_title] => RNA FOR TREATMENT OF AUTOIMMUNE DISEASES [patent_app_type] => utility [patent_app_number] => 18/333273 [patent_app_country] => US [patent_app_date] => 2023-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27881 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -51 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18333273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18755926 [patent_doc_number] => 20230359371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-09 [patent_title] => METHODS OF USING OX40 LIGAND ENCODING POLYNUCLEOTIDES [patent_app_type] => utility [patent_app_number] => 18/324724 [patent_app_country] => US [patent_app_date] => 2023-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 69079 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18324724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19203122 [patent_doc_number] => 20240175021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-30 [patent_title] => METHODS FOR MODULATING FMR1 EXPRESSION [patent_app_type] => utility [patent_app_number] => 18/314691 [patent_app_country] => US [patent_app_date] => 2023-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18535 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18314691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19225444 [patent_doc_number] => 12005074 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-11 [patent_title] => Extrahepatic delivery [patent_app_type] => utility [patent_app_number] => 18/311484 [patent_app_country] => US [patent_app_date] => 2023-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 34 [patent_no_of_words] => 79558 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18311484 [rel_patent_id] =>[rel_patent_doc_number] =>)